NOT ALL FORMULAS CONTAIN HMOs
|SIMILAC ® PRO-SERIES||ENFAMIL INFANT FORMULAS|
|Has HMOs, the most abundant solid component in breast milk after fats and lactose||✔||❌|
|First leading formula with 2'-FL HMO for immune support||✔||❌|
|Backed by more than 20 years of HMO research||✔||❌|
Reported significantly fewer respiratory infections1,2,*
Shown to support immune cell response to RSV more like the breastfed infant3,†
* Similac with 2'-FL HMO compared to control formula without 2'-FL HMO, based on a post hoc analysis of adverse events.
† Study with Similac Pro-Advance®; using cells from infant’s blood that were challenged with RSV ex vivo.
‡ Based on pediatrician recommendations.
Enfamil is not a registered trademark of Abbott.
References: 1. Marriage BJ, et al. J Pediatr Gastroenterol Nutr. 2015;61(6):649-658. 2. Reverri EJ, et al. Nutrients. 2018;10(10):1346. 3. Goehring KC, et al. J Nutr. 2016;146(12):2559-2566.
Please be aware that the website you have requested to view is intended for Healthcare Professionals and may not be owned or maintained by Abbott. A new window will open in your browser once you select “yes”. You can return to this site by clicking the back arrow.
Do you wish to continue and exit this website?